---
title: "Edwards Lifesciences to acquire TMVR developer Innovalve"
date: "2024-07-16T11:05:49.000Z"
publishedDate: "16 juillet 2024"
summary: "Edwards Lifesciences has announced it has exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since the 2017 investment, Innovalve has demonstrated progress in its programme with promising early clinical experience, Edwards Lifesciences said in a press release."
importance: ""
sourceUrl: "https://cardiovascularnews.com/edwards-lifesciences-to-acquire-innovalve/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-07-16-edwards-lifesciences-to-acquire-tmvr-developer-innovalve"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/03/edwards-corporate-2-large.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/edwards-lifesciences-to-acquire-innovalve/"
---

![Edwards Lifesciences to acquire TMVR developer Innovalve](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/03/edwards-corporate-2-large.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/edwards-lifesciences-to-acquire-innovalve/*

## L’essentiel

Edwards Lifesciences has announced it has exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since the 2017 investment, Innovalve has demonstrated progress in its programme with promising early clinical experience, Edwards Lifesciences said in a press release.

## Lien source

https://cardiovascularnews.com/edwards-lifesciences-to-acquire-innovalve/
